Want to join the conversation?
$RHI's total revenues for 3Q15 were $1.31Bil compared to $1.22Bil in year ago quarter. The increase in revenues was fueled by strong results from Protiviti, Robert Half Technology and permanent placement operations. Protiviti revenues rose 23% from one year ago when adjusted for currency.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.